-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although the Nobel Prize Committee had high hopes and hoped that one of the committees would endorse research on vaccines, which have benefited billions of people and saved countless lives, this year’s Nobel Prize in Science has been awarded for many years.
Some scientists expressed surprise and disappointment at the omission of the new coronavirus vaccine, especially the new vaccine developed using mRNA technology
Nobel Prize insiders and observers say that time, technical details and political factors mean that the chances of this year's vaccine winning the Nobel Prize are very small
"The development of the mRNA vaccine is a wonderful success story and has a huge positive impact on humans
The timing of this year is not conducive to the Nobel Prize for COVID-19
Historical experience also opposes the approval of the new crown vaccine
But Fortunato said that major discoveries tend to be discovered sooner
Brian Uzzi, a computational scientist at the Northwestern University Research Science Awards in Evanston, Illinois, believes that the Nobel Committee’s focus will go beyond vaccine development when it comes to COVID-19
However, the COVID-19 vaccine has begun to receive major scientific awards: Last month, one of the $3 million breakthrough awards was awarded to two scientists who developed improvements to suppress unnecessary immune responses.
Scientists say that if these vaccines are awarded the Nobel Prize, the committee will need to make some difficult decisions about who to commend and what to commend
Arturo Casadevall, a microbiologist at the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, Maryland, agrees.
Hansson said it will take time to solve all these problems
